|Include HF phenotype: HFrEF; HFpEF|
|Identify NYHA functional class|
|Include recent measurement of LVEF with source documentation if requested|
|Identify agent requested or additional testing required with indications supported by evidence and/or guideline statements where applicable; especially for testing requests, clinical judgment is an appropriate rationale|
|Address previous therapies used and rationale for switching or addition of treatment requested|
|Address known contraindications to use, adverse effects, and steps intended to minimize risk of drugs or procedures|
|Document when appropriate that delay or interruption in therapy may cause harm to the patient|
|Work with local pharmacy resources and pharmacy professionals to jointly address prior authorization requirements; do not hesitate to appeal decisions that are contrary to best patient care. Document all steps taken in the patient’s health record.|
HF = heart failure; EF = ejection fraction; HFpEF = heart failure with preserved ejection fraction; HFrEF = heart failure with reduced ejection fraction; LVEF = left ventricular ejection fraction; NYHA = New York Heart Association.
↵∗ Required information may vary depending on payer and state.